$BDRL
BLONDER TONGUE LABORATORIES INC Stock $bdrl

$bdrl Overview Financials Valuation SEC Filings Company Website

2016 Q1 Form 10-Q Financial Statement

#000114420416101433 Filed on May 13, 2016

Income Statement

Concept	2016 Q1	2015 Q4	2015 Q1
Revenue	$5.943M	$5.210M	$4.742M
YoY Change	25.33%	-14.03%	-15.02%
Cost Of Revenue	$3.735M	$4.750M	$3.362M
YoY Change	11.09%	24.35%	-11.99%
Gross Profit	$2.208M	$470.0K	$1.380M
YoY Change	60.0%	-79.02%	-21.46%
Gross Profit Margin	37.15%	9.02%	29.1%
Selling, General & Admin	$1.715M	$1.750M	$1.899M
YoY Change	-9.69%	-14.22%	-6.45%
% of Gross Profit	77.67%	372.34%	137.61%
Research & Development	$693.0K	$730.0K	$804.0K
YoY Change	-13.81%	-6.41%	-4.29%
% of Gross Profit	31.39%	155.32%	58.26%
Depreciation & Amortization	$120.0K	$310.0K	$121.0K
YoY Change	-0.83%	-8.82%	10.0%
% of Gross Profit	5.43%	65.96%	8.77%
Operating Expenses	$2.408M	$2.480M	$2.703M
YoY Change	-10.91%	-12.37%	-5.82%
Operating Profit	-$200.0K	-$2.010M	-$1.323M
YoY Change	-84.88%	240.68%	18.87%
Interest Expense	$88.00K	-$80.00K	$0.00
YoY Change		33.33%	-100.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$288.0K	-$2.090M	-$1.415M
YoY Change	-79.65%	226.56%	21.88%
Income Tax	$0.00	$50.00K	$0.00
% Of Pretax Income
Net Earnings	-$288.0K	-$2.140M	-$1.415M
YoY Change	-79.65%	219.4%	21.88%
Net Earnings / Revenue	-4.85%	-41.07%	-29.84%
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.04	-$0.32	-$0.23
COMMON SHARES
Basic Shares Outstanding	6.765M shares	6.555M shares	6.263M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2016 Q1	2015 Q4	2015 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$510.0K	$10.00K	$90.00K
YoY Change	466.67%	-95.65%	-18.18%
Cash & Equivalents	$513.0K	$9.000K	$94.00K
Short-Term Investments
Other Short-Term Assets	$440.0K	$280.0K	$930.0K
YoY Change	-52.69%	-56.92%	-10.58%
Inventory	$5.574M	$5.595M	$9.310M
Prepaid Expenses
Receivables	$3.151M	$2.432M	$2.360M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$9.676M	$8.313M	$12.69M
YoY Change	-23.75%	-33.84%	3.53%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.503M	$3.621M	$3.930M
YoY Change	-10.87%	-7.7%	8.29%
Goodwill	$493.0K	$493.0K
YoY Change		0.0%
Intangibles	$361.0K	$458.0K
YoY Change		-28.99%
Long-Term Investments
YoY Change
Other Assets	$117.0K	$117.0K	$2.050M
YoY Change	-94.29%	317.86%	1266.67%
Total Long-Term Assets	$7.523M	$7.917M	$8.870M
YoY Change	-15.19%	-8.78%	-4.14%
TOTAL ASSETS
Total Short-Term Assets	$9.676M	$8.313M	$12.69M
Total Long-Term Assets	$7.523M	$7.917M	$8.870M
Total Assets	$17.20M	$16.23M	$21.56M
YoY Change	-20.23%	-23.6%	0.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.999M	$1.387M	$2.370M
YoY Change	-15.65%	2.66%	69.65%
Accrued Expenses	$1.030M	$960.0K	$1.170M
YoY Change	-11.97%	10.34%	56.0%
Deferred Revenue
YoY Change
Short-Term Debt	$2.850M	$2.660M	$1.700M
YoY Change	67.65%	109.45%	36.0%
Long-Term Debt Due	$3.548M	$3.604M	$3.800M
YoY Change	-6.63%	1160.14%	-5.0%
Total Short-Term Liabilities	$9.612M	$8.622M	$9.060M
YoY Change	6.09%	126.66%	22.09%
LONG-TERM LIABILITIES
Long-Term Debt	$3.000K	$10.00K	$30.00K
YoY Change	-90.0%	-99.72%	-67.74%
Other Long-Term Liabilities	$0.00	$0.00
YoY Change
Total Long-Term Liabilities	$3.000K	$10.00K	$30.00K
YoY Change	-90.0%	-99.72%	-67.74%
TOTAL LIABILITIES
Total Short-Term Liabilities	$9.612M	$8.622M	$9.060M
Total Long-Term Liabilities	$3.000K	$10.00K	$30.00K
Total Liabilities	$9.615M	$8.632M	$9.180M
YoY Change	4.74%	16.48%	22.17%
SHAREHOLDERS EQUITY
Retained Earnings	-$12.49M	-$12.20M	-$5.511M
YoY Change	126.57%	197.8%	26.54%
Common Stock	$26.41M	$26.37M	$26.50M
YoY Change	-0.32%	-0.28%	0.9%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$5.634M	$5.634M	$7.255M
YoY Change	-22.34%	-22.34%	-0.73%
Treasury Stock Shares	1.699M shares	1.699M shares	2.202M shares
Shareholders Equity	$7.126M	$7.369M	$12.38M
YoY Change
Total Liabilities & Shareholders Equity	$17.20M	$16.23M	$21.56M
YoY Change	-20.23%	-23.6%	0.23%

Cashflow Statement

Concept	2016 Q1	2015 Q4	2015 Q1
OPERATING ACTIVITIES
Net Income	-$288.0K	-$2.140M	-$1.415M
YoY Change	-79.65%	219.4%	21.88%
Depreciation, Depletion And Amortization	$120.0K	$310.0K	$121.0K
YoY Change	-0.83%	-8.82%	10.0%
Cash From Operating Activities	-$20.00K	-$440.0K	-$360.0K
YoY Change	-94.44%	-59.63%	-192.31%
INVESTING ACTIVITIES
Capital Expenditures	$2.000K	$0.00	$132.0K
YoY Change	-98.48%	-100.0%	355.17%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$10.00K	$0.00	-$130.0K
YoY Change	-92.31%	-100.0%	-45.83%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net	$63.00K		$69.00K
YoY Change	-8.7%		-1.43%
Cash From Financing Activities	530.0K	160.0K	360.0K
YoY Change	47.22%	-36.0%	-460.0%
NET CHANGE
Cash From Operating Activities	-20.00K	-440.0K	-360.0K
Cash From Investing Activities	-10.00K	0.000	-130.0K
Cash From Financing Activities	530.0K	160.0K	360.0K
Net Change In Cash	500.0K	-280.0K	-130.0K
YoY Change	-484.62%	-76.47%	-360.0%
FREE CASH FLOW
Cash From Operating Activities	-$20.00K	-$440.0K	-$360.0K
Capital Expenditures	$2.000K	$0.00	$132.0K
Free Cash Flow	-$22.00K	-$440.0K	-$492.0K
YoY Change	-95.53%	-69.44%	-236.29%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2015Q4	us-gaap	Assets Current AssetsCurrent	8313000	USD
CY2015Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2432000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3621000	USD
CY2016Q1	us-gaap	Inventory Net InventoryNet	5574000	USD
CY2015Q4	us-gaap	Inventory Net InventoryNet	5595000	USD
CY2015Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	458000	USD
CY2016Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1741000	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	513000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9000	USD
CY2016Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3151000	USD
CY2016Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	438000	USD
CY2016Q1	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2015Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	277000	USD
CY2016Q1	us-gaap	Assets Current AssetsCurrent	9676000	USD
CY2016Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3503000	USD
CY2016Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1168000	USD
CY2015Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1168000	USD
CY2016Q1	dei	Trading Symbol TradingSymbol	BDR
CY2016Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	6764736	shares
CY2016Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	361000	USD
CY2015Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	117000	USD
CY2016Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	3548000	USD
CY2016Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1999000	USD
CY2016Q1	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	666000	USD
CY2016Q1	us-gaap	Pension And Other Postretirement Defined Benefit Plans Current Liabilities PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities	54000	USD
CY2015Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	6000	USD
CY2015Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	519000	USD
CY2015Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	10000	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	129000	USD
CY2015Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2015Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q1	us-gaap	Treasury Stock Value TreasuryStockValue	5634000	USD
CY2015Q4	us-gaap	Treasury Stock Value TreasuryStockValue	5634000	USD
CY2016Q1	us-gaap	Stockholders Equity StockholdersEquity	7126000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1784000	USD
CY2015Q4	us-gaap	Goodwill Goodwill	493000	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	7369000	USD
CY2016Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	117000	USD
CY2016Q1	us-gaap	Line Of Credit LineOfCredit	2854000	USD
CY2015Q4	us-gaap	Line Of Credit LineOfCredit	2664000	USD
CY2015Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	3604000	USD
CY2015Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1387000	USD
CY2015Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	388000	USD
CY2015Q4	us-gaap	Pension And Other Postretirement Defined Benefit Plans Current Liabilities PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities	54000	USD
CY2016Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	6000	USD
CY2016Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	308000	USD
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	8622000	USD
CY2016Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	3000	USD
CY2016Q1	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	129000	USD
CY2016Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2016Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2015Q4	us-gaap	Common Stock Value CommonStockValue	8000	USD
CY2015Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	26361000	USD
CY2016Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-12486000	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-12198000	USD
CY2016Q1	us-gaap	Inventory Noncurrent InventoryNoncurrent	1308000	USD
CY2015Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	1444000	USD
CY2016Q1	us-gaap	Goodwill Goodwill	493000	USD
CY2016Q1	us-gaap	Liabilities Current LiabilitiesCurrent	9612000	USD
CY2016Q1	us-gaap	Common Stock Value CommonStockValue	8000	USD
CY2016Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	26406000	USD
CY2015Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	4742000	USD
CY2016Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	5943000	USD
CY2015Q1	us-gaap	Cost Of Goods Sold CostOfGoodsSold	3362000	USD
CY2016Q1	us-gaap	Cost Of Goods Sold CostOfGoodsSold	3735000	USD
CY2015Q1	us-gaap	Gross Profit GrossProfit	1380000	USD
CY2016Q1	us-gaap	Gross Profit GrossProfit	2208000	USD
CY2015Q1	us-gaap	Selling Expense SellingExpense	843000	USD
CY2016Q1	us-gaap	Selling Expense SellingExpense	652000	USD
CY2015Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1056000	USD
CY2016Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1063000	USD
CY2015Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	804000	USD
CY2016Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	693000	USD
CY2015Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1323000	USD
CY2016Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-200000	USD
CY2015Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-92000	USD
CY2016Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-88000	USD
CY2015Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1415000	USD
CY2016Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-288000	USD
CY2015Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2016Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2015Q1	us-gaap	Net Income Loss NetIncomeLoss	-1415000	USD
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	-288000	USD
CY2015Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.23
CY2016Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.04
CY2016Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	6765000	shares
CY2015Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	6263000	shares
CY2015Q1	us-gaap	Depreciation Depreciation	121000	USD
CY2016Q1	us-gaap	Depreciation Depreciation	120000	USD
CY2015Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	217000	USD
CY2016Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	144000	USD
CY2015Q1	us-gaap	Share Based Compensation ShareBasedCompensation	57000	USD
CY2016Q1	us-gaap	Share Based Compensation ShareBasedCompensation	45000	USD
CY2015Q1	us-gaap	Inventory Write Down InventoryWriteDown	31000	USD
CY2016Q1	us-gaap	Inventory Write Down InventoryWriteDown	48000	USD
CY2015Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-69000	USD
CY2016Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	719000	USD
CY2015Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	451000	USD
CY2016Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-109000	USD
CY2015Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	278000	USD
CY2016Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	161000	USD
CY2015Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	30000	USD
CY2016Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	0	USD
CY2015Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1317000	USD
CY2016Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	679000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-362000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-17000	USD
CY2015Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	132000	USD
CY2016Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-133000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-6000	USD
CY2015Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	69000	USD
CY2016Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	63000	USD
CY2015Q1	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	426000	USD
CY2016Q1	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	190000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	357000	USD
CY2015Q1	us-gaap	Interest Expense InterestExpense	0	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	527000	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-138000	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	504000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	232000	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	94000	USD
CY2016Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	239000	USD
CY2015Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	239000	USD
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8465	shares
CY2015Q1	us-gaap	Interest Paid InterestPaid	66000	USD
CY2016Q1	us-gaap	Interest Paid InterestPaid	76000	USD
CY2016Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8465	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6766	shares
CY2015Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	1699	shares
CY2015Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	4913000	USD
CY2016Q1	us-gaap	Inventory Lifo Reserve InventoryLIFOReserve	4338000	USD
CY2015Q4	us-gaap	Inventory Lifo Reserve InventoryLIFOReserve	4426000	USD
CY2016Q1	us-gaap	Assets Assets	17199000	USD
CY2015Q4	us-gaap	Assets Assets	16230000	USD
CY2016Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	17199000	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16230000	USD
CY2016Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	1699000	shares
CY2016Q1	us-gaap	Operating Expenses OperatingExpenses	2408000	USD
CY2015Q1	us-gaap	Operating Expenses OperatingExpenses	2703000	USD
CY2015Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
CY2016Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
CY2016Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	4000	USD
CY2015Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1000	USD
CY2016Q1	us-gaap	Interest Expense InterestExpense	6000	USD
CY2016Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	4469000	USD
CY2015Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	4820000	USD
CY2016Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	1963000	USD
CY2015Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	1732000	USD
CY2016Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	4788000	USD
CY2015Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2016Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2015Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000	shares
CY2016Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000	shares
CY2015Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2016Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000	shares
CY2016Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000	shares
CY2016Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;WIDOWS: 1; TEXT-TRANSFORM: none; TEXT-INDENT: 0px; MARGIN: 0pt 0px; LETTER-SPACING: normal; FONT: 10pt 'Times New Roman', Times, serif; WHITE-SPACE: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal"> </div> <table style="WIDOWS: 1; TEXT-TRANSFORM: none; MARGIN-TOP: 0px; TEXT-INDENT: 0px; LETTER-SPACING: normal; FONT: 10pt 'Times New Roman', Times, serif; MARGIN-BOTTOM: 0px; WORD-SPACING: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="WIDTH: 0px"></td> <td style="TEXT-ALIGN: left; WIDTH: 0.5in"> <div><i>(a)</i></div> </td> <td style="TEXT-ALIGN: justify"> <div><i>Use of Estimates</i></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;WIDOWS: 1; TEXT-TRANSFORM: none; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; LETTER-SPACING: normal; FONT: 10pt 'Times New Roman', Times, serif; WHITE-SPACE: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;WIDOWS: 1; TEXT-TRANSFORM: none; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; LETTER-SPACING: normal; FONT: 10pt 'Times New Roman', Times, serif; WHITE-SPACE: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal" align="justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2016Q1	us-gaap	Derivatives Reporting Of Derivative Activity DerivativesReportingOfDerivativeActivity	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;WIDOWS: 1; TEXT-TRANSFORM: none; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; LETTER-SPACING: normal; FONT: 10pt 'Times New Roman', Times, serif; WHITE-SPACE: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal" align="justify"></div> <table style="WIDOWS: 1; TEXT-TRANSFORM: none; MARGIN-TOP: 0px; TEXT-INDENT: 0px; LETTER-SPACING: normal; FONT: 10pt 'Times New Roman', Times, serif; MARGIN-BOTTOM: 0px; WORD-SPACING: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal" cellspacing="0" cellpadding="0"> <tr style="TEXT-ALIGN: justify; VERTICAL-ALIGN: top"> <td style="WIDTH: 0px"></td> <td style="TEXT-ALIGN: left; WIDTH: 0.5in"> <div><i>(b)</i></div> </td> <td style="TEXT-ALIGN: justify"> <div><i>Derivative Financial Instruments</i></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;WIDOWS: 1; TEXT-TRANSFORM: none; TEXT-INDENT: 0px; MARGIN: 0pt 0px; LETTER-SPACING: normal; FONT: 10pt 'Times New Roman', Times, serif; WHITE-SPACE: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal" align="justify"><i> </i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;WIDOWS: 1; TEXT-TRANSFORM: none; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; LETTER-SPACING: normal; FONT: 10pt 'Times New Roman', Times, serif; WHITE-SPACE: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal" align="justify">The Company evaluates its convertible instruments to determine if those contracts or embedded components of those contracts qualify as derivative financial instruments to be separately accounted for in accordance with Topic 815 of the Financial Accounting Standards Board (“<b>FASB</b>”) Accounting Standards Codification (<b>“ASC</b>”). The accounting treatment of derivative financial instruments requires that the Company record the embedded conversion option at its fair value as of the inception date of the agreement and at fair value as of each subsequent balance sheet date. Any change in fair value is recorded as non-operating, non-cash income or expense for each reporting period at each balance sheet date. The Company reassesses the classification of its derivative instruments at each balance sheet date. If the classification changes as a result of events during the period, the contract is reclassified as of the date of the event that caused the reclassification.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;WIDOWS: 1; TEXT-TRANSFORM: none; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; LETTER-SPACING: normal; FONT: 10pt 'Times New Roman', Times, serif; WHITE-SPACE: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;WIDOWS: 1; TEXT-TRANSFORM: none; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; LETTER-SPACING: normal; FONT: 10pt 'Times New Roman', Times, serif; WHITE-SPACE: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal" align="justify">The Binomial Lattice Model was used to estimate the fair value of the conversion options that is classified as a derivative liability on the condensed consolidated balance sheets. The model includes subjective input assumptions that can materially affect the fair value estimates. The expected volatility is estimated based on the most recent historical period of time equal to the weighted average life of the conversion options.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;WIDOWS: 1; TEXT-TRANSFORM: none; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; LETTER-SPACING: normal; FONT: 10pt 'Times New Roman', Times, serif; WHITE-SPACE: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;WIDOWS: 1; TEXT-TRANSFORM: none; TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; LETTER-SPACING: normal; FONT: 10pt 'Times New Roman', Times, serif; WHITE-SPACE: normal; COLOR: rgb(0,0,0); WORD-SPACING: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal" align="justify">Conversion options are recorded as a discount to the host instrument and are amortized as interest expense over the life of the underlying instrument.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2016Q1	us-gaap	Inventory Gross InventoryGross	11220000	USD
CY2015Q4	us-gaap	Inventory Gross InventoryGross	11465000	USD
CY2016Q1	bdr	Inventory Value Before Reserves InventoryValueBeforeReserves	5646000	USD
CY2015Q4	bdr	Inventory Value Before Reserves InventoryValueBeforeReserves	5870000	USD
CY2016Q1	bdr	Percentage Of Fifo Inventory Non Current For Finished Goods PercentageOfFifoInventoryNonCurrentForFinishedGoods	0.72	pure
CY2015	bdr	Percentage Of Fifo Inventory Non Current For Finished Goods PercentageOfFifoInventoryNonCurrentForFinishedGoods	0.73	pure
CY2016Q1	us-gaap	Inventory Related Text InventoryRelatedText	Inventories are stated at the lower of cost, determined by the first-in, first-out (“FIFO”) method, or market
CY2016Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	177000	USD
CY2015Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	0	USD
CY2016Q1	us-gaap	Convertible Subordinated Debt Noncurrent ConvertibleSubordinatedDebtNoncurrent	329000	USD
CY2015Q4	us-gaap	Convertible Subordinated Debt Noncurrent ConvertibleSubordinatedDebtNoncurrent	100000	USD
CY2016Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	400000	USD
CY2015Q1	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	USD

Files In Submission

Name	View Source	Status
0001144204-16-101433-index-headers.html	Edgar Link	pending
0001144204-16-101433-index.html	Edgar Link	pending
0001144204-16-101433.txt	Edgar Link	pending
0001144204-16-101433-xbrl.zip	Edgar Link	pending
bdr-20160331.xml	Edgar Link	completed
bdr-20160331.xsd	Edgar Link	pending
bdr-20160331_cal.xml	Edgar Link	unprocessable
bdr-20160331_def.xml	Edgar Link	unprocessable
bdr-20160331_lab.xml	Edgar Link	unprocessable
bdr-20160331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v439240_10q.htm	Edgar Link	pending
v439240_ex31-1.htm	Edgar Link	pending
v439240_ex31-2.htm	Edgar Link	pending
v439240_ex32-1.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BDRL
BLONDER TONGUE LABORATORIES INC Stock $bdrl

2016 Q1 Form 10-Q Financial Statement

#000114420416101433 Filed on May 13, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BDRL BLONDER TONGUE LABORATORIES INC Stock $bdrl

2016 Q1 Form 10-Q Financial Statement

#000114420416101433 Filed on May 13, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BDRL
BLONDER TONGUE LABORATORIES INC Stock $bdrl